Email this article Pharmacoepidemiologic usage analysis of neuroleptics for treating paranoid schizophrenia in psychiatry hospital
- Authors: Kuchaeva A.V.1,2, Ziganshina L.E.1,2, Yakhin K.K.1,2, Minnetdinova L.M.1,2, Gatin F.F.1,2, Mikhailova E.B.1,2
-
Affiliations:
- Kazan State Medical Academy of Postgraduate Education
- Kazan State Medical University
- Issue: Vol XXXV, No 1-2 (2003)
- Pages: 39-43
- Section: Original article
- URL: https://journals.rcsi.science/1027-4898/article/view/89664
- DOI: https://doi.org/10.17816/nb89664
- ID: 89664
Cite item
Full Text
Abstract
During pharmacotherapy with neuroleptics of paranoid schizophrenia patients there had been studied retrospectively and perspectively frequency and expressiveness of side effects. There was determined a correlation between neuro-motor reaction expressiveness of neuroleptics and sex, age and time of intake. The obtained results can be very useful to a practioner for his/ her rational usage of psychotropic medications, removal of neuro- motor reaction and making decision in continuation of neuroleptic therapy.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
A. V. Kuchaeva
Kazan State Medical Academy of Postgraduate Education; Kazan State Medical University
Author for correspondence.
Email: info@eco-vector.com
Russian Federation, Kazan; Kazan
L. E. Ziganshina
Kazan State Medical Academy of Postgraduate Education; Kazan State Medical University
Email: info@eco-vector.com
Russian Federation, Kazan; Kazan
K. K. Yakhin
Kazan State Medical Academy of Postgraduate Education; Kazan State Medical University
Email: info@eco-vector.com
Russian Federation, Kazan; Kazan
L. M. Minnetdinova
Kazan State Medical Academy of Postgraduate Education; Kazan State Medical University
Email: info@eco-vector.com
Russian Federation, Kazan; Kazan
F. F. Gatin
Kazan State Medical Academy of Postgraduate Education; Kazan State Medical University
Email: info@eco-vector.com
Russian Federation, Kazan; Kazan
E. B. Mikhailova
Kazan State Medical Academy of Postgraduate Education; Kazan State Medical University
Email: info@eco-vector.com
Russian Federation, Kazan; Kazan
References
- Тиганов А.С. Руководство по психиатрии. —2000. —Т. 1.
- Шакиров И.А., Волынец С.И., Костейко Л.А. Комбинированное лечение больных эглонилом и лепонексом в условиях дневного психиатрического стационара / Новые методы диагностики и лечения психических заболеваний: сб. науч. тр. / Белорус. респ. науч. о-во психиатров, Респ. клинич. психиатр. больница МЗ БССР. — Минск, 1989. — С.178—180.
- American Psychiatric Association (1997), Practice guideline for the treatment of patients with schizophrenia. // Am. J. Psychiatry. Vol. 154(4). — P. 1—63. Prescription des neuroleptiques. In Recommendations de Pratique Clinique (tome 2) ANDEM. — Paris, 1994 — P. 211—242.
- Findling R.L. Paediatric psychopharmacology: closing the gap between science and practice (In Process Citation). Expert Opin Pharmacother. — 2001 Apr. — Vol. 2(4). — P. 523—525.
- Gross G., Huber G. // Psychopathology. — 1986. — Vol. 19(1). — P. 50—59.
- Jacobsen L.K, Rapoport J.L (1998) // J. Child. Psychol. Psychiatry. — Vol. 39. P.101—113.
- Jeste D.V., Lacro J.P. et al. // Am. J. Psychiatry. — 1999. — Vol. 156(2).
- Joy C.B., Adams C.E., Lawrie S.M. Haloperidol versus placebo for schizophrenia (Cochrane Review). In: The Cochrane Library, Issue 3, 2002. Oxford: Update Software.
- Krieger S., Lis S., Gallhofer B. // Acta Psychiatr. Scand. Suppl. — 2001. — Vol. (408). — P. 18—27.
- Lees A.J. MD, MRCP Consultant Neurologist National Hospitals for Nervous Diseases University College Hospital end Whittington Hospital, London U.K. “Tics and Related Disorders. — 1985.
- Muscettola G., Casiello M., Bollini P., Sebastiany G., Pampallona S., Tognoni G. //Acta Psychiatr. Scand. — 1987. — Vol. 75 —P. 55—61.
- McGrath J.J., Soares KVS Benzodiazepines for neuroleptic-induced tardive dyskinesia. The Cochrane Library. — 1999. — Issue 4. — P. 1—2.
- McGrath J.J., Soares K.V. Benzodiazepines for neuroleptic-induced tardive dyskinesia. Cochrane Database Syst Rev. — 2000(2).
- McClellan J.M., Werry J.S., Ham M. // J. Autism. Dev. Disord. — 1993. — Vol. 23. — P. 243—262.
- Strom B.L. Pharmacoepidemiology / (Ed.) - 2nd ed. — N.-Y., 1994.
